Immunovant, Inc. IMVT Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $5.06B.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s market capitalization?
- Immunovant, Inc. (IMVT) reported market capitalization of $5.06B in Q1 2026.
- How has Immunovant, Inc.'s market capitalization changed year-over-year?
- Immunovant, Inc.'s market capitalization increased by 74.2% year-over-year, from $2.9B to $5.06B.
- What is the long-term trend for Immunovant, Inc.'s market capitalization?
- Over 5 years (2021 to 2026), Immunovant, Inc.'s market capitalization has grown at a 26.3% compound annual growth rate (CAGR), from $1.57B to $5.06B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.